ALZHEIMERS UNVEILED – A HOLISTIC JOURNEY THROUGH SCIENCE AND CARE

Alzheimer's disease (AD) represents a significant and expanding global health challenge, with projections indicating a doubling of affected individuals every five years by 2050.This neurodegenerative disorder is delineated by the accumulation of amyloid plaques, neurofibrillary tangles, and subsequent neuronal and synaptic degeneration, leading to progressive cognitive decline.While the exact etiology of AD remains elusive, age, genetics, cardiovascular disease, traumatic brain injury, type 2 diabetes mellitus, obesity, and environmental factors are recognized as key risk factors.This review provides a comprehensive overview of AD, encompassing epidemiology, pathogenesis, risk factors, clinical stages, and treatment options.Despite the absence of a cure, current pharmacological interventions aim to alleviate symptoms and improve quality of life.Emerging disease-modifying treatments targeting amyloid-beta offer promise for slowing disease progression.Understanding the multifaceted nature of AD is essential for developing effective interventions and mitigating its devastating impact on individuals, families, and society.

Publication Details

Journal
International Journal of Biology Pharmacy and Allied Sciences
Published
2025-07-30
DOI
https://doi.org/10.31032/ijbpas/2025/14.8.9283
Primary Topic
Health, Environment, Cognitive Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALZHEIMERS UNVEILED – A HOLISTIC JOURNEY THROUGH SCIENCE AND CARE

International Journal of Biology Pharmacy and Allied Sciences
Health, Environment, Cognitive Aging
article

ALZHEIMERS UNVEILED – A HOLISTIC JOURNEY THROUGH SCIENCE AND CARE

article en

Abstract

Alzheimer's disease (AD) represents a significant and expanding global health challenge, with projections indicating a doubling of affected individuals every five years by 2050.This neurodegenerative disorder is delineated by the accumulation of amyloid plaques, neurofibrillary tangles, and subsequent neuronal and synaptic degeneration, leading to progressive cognitive decline.While the exact etiology of AD remains elusive, age, genetics, cardiovascular disease, traumatic brain injury, type 2 diabetes mellitus, obesity, and environmental factors are recognized as key risk factors.This review provides a comprehensive overview of AD, encompassing epidemiology, pathogenesis, risk factors, clinical stages, and treatment options.Despite the absence of a cure, current pharmacological interventions aim to alleviate symptoms and improve quality of life.Emerging disease-modifying treatments targeting amyloid-beta offer promise for slowing disease progression.Understanding the multifaceted nature of AD is essential for developing effective interventions and mitigating its devastating impact on individuals, families, and society.

International Journal of Biology Pharmacy and Allied SciencesVol. 14(8)
Openalex Percentile: Top 76%
Health, Environment, Cognitive Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ALZHEIMERS UNVEILED – A HOLISTIC JOURNEY THROUGH SCIENCE AND CARE · International Journal of Biology Pharmacy and Allied Sciences (2025) | TGRS Research Map | TGRS